Tick-borne Illness and Clothing Study of Rhode Island
NCT02613585 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135
Last updated 2021-03-10
Summary
Lyme and other tick-borne diseases pose a significant health threat to outdoor workers. This study is a double-blind randomized controlled trial of outdoor workers in Rhode Island and the surrounding area that will address the following study aims: 1) Evaluate the effectiveness of LLPI clothing in preventing tick bites among outdoor workers in Lyme endemic areas; 2) Measure the urine levels of permethrin metabolites in study subjects; and 3) Measure the loss over time of knockdown activity against ticks and of permethrin in LLPI clothing.
Conditions
- Tick Bites
- Tick-borne Diseases
Interventions
- OTHER
-
Permethrin Impregnated Clothing
Uniforms and work clothing treated with permethrin according to proprietary process used by Insect Shield, Inc.
Sponsors & Collaborators
-
University of Rhode Island
collaborator OTHER -
East Carolina University
collaborator OTHER -
National Institute for Occupational Safety and Health (NIOSH/CDC)
collaborator FED -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Steven R Meshnick, MD, PhD · University of North Carolina, Chapel Hill
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2019-03-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Searching for Persistence of Infection in Lyme Disease
NCT01143558 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Next Generation Sequencing Detection of Lyme Disease
NCT03505879 ·Status: COMPLETED
-
Ceftriaxone for Post-Treatment Lyme Disease
NCT06785402 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Evaluation and Follow-up of People With Tick-borne Diseases
NCT04318925 ·Status: WITHDRAWN
-
Study of the Clinical, Microbiological and Epidemiological Characteristics of Recurrent Imported Borreliosis Confirmed by the CNR Borrelia
NCT07335965 ·Status: RECRUITING
-
Understanding Tick-borne Diseases
NCT03501407 ·Status: UNKNOWN
-
Lyme Test Indication Combinations (LyTIC) Study
NCT03201042 ·Status: TERMINATED
-
An Intervention in a Primary Healthcare Setting to Reduce Lyme Neuroborreliosis Treatment Delay
NCT03820999 ·Status: UNKNOWN ·Phase: NA
-
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
NCT00237016 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
NCT07226882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
NCT02741609 ·Status: TERMINATED ·Phase: NA
-
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT00138801 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
NCT00028080 ·Status: RECRUITING
-
Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
NCT03581279 ·Status: TERMINATED ·Phase: NA
-
Perceptions,Social Representations and Experience of Lyme Borreliosis and Ticks in Adolescents Likely to be Infected and Their Parents
NCT05678478 ·Status: COMPLETED
-
Study and Treatment of Post Lyme Disease (STOP-LD)
NCT00000937 ·Status: COMPLETED ·Phase: PHASE3
-
Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever
NCT06045481 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Risk of Exposure and Prevention of Ticks and Tick-borne Diseases Among Foresters in Alsace
NCT06492668 ·Status: RECRUITING
-
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
NCT03769194 ·Status: COMPLETED ·Phase: PHASE2
-
Tetracycline Treatment Tolerability Trial
NCT05219929 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.
NCT07230028 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
NCT05634811 ·Status: COMPLETED ·Phase: PHASE3
-
Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
NCT06611111 ·Status: RECRUITING ·Phase: EARLY_PHASE1